176 related articles for article (PubMed ID: 10452792)
21. Beta2-agonist eutomers: a rational option for the treatment of asthma?
Boulton DW; Fawcett JP
Am J Respir Med; 2002; 1(5):305-11. PubMed ID: 14720033
[TBL] [Abstract][Full Text] [Related]
22. Levalbuterol for asthma: a better treatment?
Kelly HW
Curr Allergy Asthma Rep; 2007 Jul; 7(4):310-4. PubMed ID: 17547854
[TBL] [Abstract][Full Text] [Related]
23. Comparison of racemic albuterol and levalbuterol for treatment of acute asthma.
Carl JC; Myers TR; Kirchner HL; Kercsmar CM
J Pediatr; 2003 Dec; 143(6):731-6. PubMed ID: 14657817
[TBL] [Abstract][Full Text] [Related]
24. (R)-albuterol for asthma: pro [a.k.a. (S)-albuterol for asthma: con].
Ameredes BT; Calhoun WJ
Am J Respir Crit Care Med; 2006 Nov; 174(9):965-9; discussion 972-4. PubMed ID: 17060667
[TBL] [Abstract][Full Text] [Related]
25. Single-isomer levalbuterol: a review of the acute data.
Nowak R
Curr Allergy Asthma Rep; 2003 Mar; 3(2):172-8. PubMed ID: 12562558
[TBL] [Abstract][Full Text] [Related]
26. The cost effectiveness of levalbuterol versus racemic albuterol.
Quinn C
Am J Manag Care; 2004 Jul; 10(5 Suppl):S153-7. PubMed ID: 15354680
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial.
Berger WE; Milgrom H; Skoner DP; Tripp K; Parsey MV; Baumgartner RA;
Curr Med Res Opin; 2006 Jun; 22(6):1217-26. PubMed ID: 16846555
[TBL] [Abstract][Full Text] [Related]
28. Population pharmacokinetics of (R)-albuterol and (S)-albuterol in pediatric patients aged 4-11 years with asthma.
Maier G; Rubino C; Hsu R; Grasela T; Baumgartner RA
Pulm Pharmacol Ther; 2007; 20(5):534-42. PubMed ID: 16891136
[TBL] [Abstract][Full Text] [Related]
29. A comparison of heart rate changes associated with levalbuterol and racemic albuterol in pediatric cardiology patients.
Kelly A; Kennedy A; John BM; Duane B; Lemanowicz J; Little J
Ann Pharmacother; 2013 May; 47(5):644-50. PubMed ID: 23613097
[TBL] [Abstract][Full Text] [Related]
30. Levalbuterol compared to racemic albuterol: efficacy and outcomes in patients hospitalized with COPD or asthma.
Truitt T; Witko J; Halpern M
Chest; 2003 Jan; 123(1):128-35. PubMed ID: 12527613
[TBL] [Abstract][Full Text] [Related]
31. Retrospective comparison of nebulized levalbuterol and albuterol for adverse events in patients with acute airflow obstruction.
Scott VL; Frazee LA
Am J Ther; 2003; 10(5):341-7. PubMed ID: 12975718
[TBL] [Abstract][Full Text] [Related]
32. An evaluation of levalbuterol HFA in the prevention of exercise-induced bronchospasm.
Pearlman DS; Rees W; Schaefer K; Huang H; Andrews WT
J Asthma; 2007 Nov; 44(9):729-33. PubMed ID: 17994402
[TBL] [Abstract][Full Text] [Related]
33. Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma.
Hamilos DL; D'Urzo A; Levy RJ; Marcus M; Tripp K; Parsey M; Baumgartner RA; McVicar WK
Ann Allergy Asthma Immunol; 2007 Dec; 99(6):540-8. PubMed ID: 18219836
[TBL] [Abstract][Full Text] [Related]
34. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
[TBL] [Abstract][Full Text] [Related]
35. Asthma pathophysiology and evidence-based treatment of severe exacerbations.
Schreck DM
Am J Health Syst Pharm; 2006 May; 63(10 Suppl 3):S5-13. PubMed ID: 16679429
[TBL] [Abstract][Full Text] [Related]
36. Levalbuterol kinetics.
Lipworth BJ; Clearie K
J Allergy Clin Immunol; 2009 Jan; 123(1):275. PubMed ID: 19130946
[No Abstract] [Full Text] [Related]
37. Clinical outcomes of levalbuterol versus racemic albuterol in pediatric patients with asthma: Propensity score matching approach in a medicaid population.
Yuan J; Lu ZK; Zhang Y; Wu J; Love BL; Schulz RM
Pediatr Pulmonol; 2017 Apr; 52(4):516-523. PubMed ID: 27701831
[TBL] [Abstract][Full Text] [Related]
38. Question from the clinician: levalbuterol in managing pediatric asthma.
Abbott MB; Levin RH; Miller JA
Pediatr Rev; 2002 Nov; 23(11):401-3. PubMed ID: 12415020
[No Abstract] [Full Text] [Related]
39. A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults.
Nowak R; Emerman C; Hanrahan JP; Parsey MV; Hanania NA; Claus R; Schaefer K; Baumgartner RA;
Am J Emerg Med; 2006 May; 24(3):259-67. PubMed ID: 16635694
[TBL] [Abstract][Full Text] [Related]
40. A patient satisfaction survey comparing levalbuterol with racemic albuterol in children.
Berger WE; Ames DE; Harrison D
Allergy Asthma Proc; 2004; 25(6):437-44. PubMed ID: 15709455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
